Mirum Pharmaceuticals (MIRM) PT Raised to $152 at Morgan Stanley

October 13, 2026 5:18 AM

Morgan Stanley analyst Michael E Ulz raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $152.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found